Clinical trial
Effect of Trazodone on Obstructive Sleep Apnea Endotypes and Severity
NCT06286189 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Trazodone on Obstructive Sleep Apnea Endotypes and Severity
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- January 1, 2024
- Completion date
- June 1, 2026
- Enrollment
- 18 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obstructive sleep apnea